Enlivex Therapeutics Ltd

XNAS:ENLV  
0.93
-0.03 (-3.14%)
7:48:20 PM EDT: $0.94 +0.02 (+1.71%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Enlivex Therapeutics Ltd Stock, XNAS:ENLV

14 Einstein Street, 14 Einstein Street, Ness Ziona, Tel Aviv 7403618
Israel
Phone: +972.8.662.3301
Number of Employees: 49
http://www.enlivex.com

Description

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.